Trial NL80852.028.22

Trial NL80852.028.22 - n.a.

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON53829

Enrollment

Registered

2022-09-07

Start date

2023-04-12

Completion date

Unknown

Last updated

2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Publication withdrawn by sponsor

Interventions

Publication withdrawn by sponsor

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Publication withdrawn by sponsor

Exclusion criteria

Exclusion criteria: Publication withdrawn by sponsor

Design outcomes

Primary

Measure	Time frame
Publication withdrawn by sponsor	—

Secondary

Measure	Time frame
Publication withdrawn by sponsor	—

Countries

Argentina, Australia, Austria, Belgium, Bosnia and Herzegovina, Brazil, Bulgaria, Canada, Chile, China, Croatia, Czechia, Denmark, Estonia, Finland, France, Georgia, Germany, Greece, Hungary, India, Israel, Italy, Japan, Jordan, Korea (the Republic of), Latvia, Lithuania, Malaysia, Mexico, Netherlands, New Zealand, Norway, Poland, Portugal, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Taiwan (Province of China), Turkey, United Kingdom, United States of America

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)